Effects of sodium-glucose cotransporter 2 inhibitor, tofogliflozin, on the indices of renal tubular function in patients with type 2 diabetes.

Kiyohide NunoiYuichi SatoKohei KakuAkihiro YoshidaHideki Suganami

Published in: Endocrinology, diabetes & metabolism (2018)

Logarithmic reductions in the renal tubular indices, via SGLT2 inhibition, were observed in patients with T2DM. TOFO may not only improve the degree of albuminuria but may also have protective effects on the tubules.

Keyphrases

high glucose
type diabetes
endothelial cells
skeletal muscle
insulin resistance